Cardiol Therapeutics Inc. (CRDL)
NASDAQ: CRDL · Real-Time Price · USD
1.000
-0.040 (-3.85%)
At close: Nov 13, 2026, 4:00 PM EST
1.040
+0.040 (4.00%)
After-hours: Nov 13, 2026, 7:31 PM EST
Cardiol Therapeutics Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Cardiol Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $8.40. The average 1-year stock price forecast is 740.10% higher than the current stock price, while the lowest is $4.96 (+395.80%) and the highest is $10.82 (+982.00%).
Price Target: $8.40 (+740.10%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cardiol Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $9 | Buy | Reiterates | $9 | +800.00% | Nov 13, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $10 | Buy | Maintains | $10 | +900.00% | Oct 29, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Initiates $11 | Buy | Initiates | $11 | +1,000.00% | Aug 26, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
2.00M
EPS This Year
-0.32
from -0.39
EPS Next Year
-0.33
from -0.32
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.